Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Gabapentin Fig1)
Gabapentin Tablet, Film Coated
Product Images NDC 63187-148
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63187-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Gabapentin Fig2)
This is a chart displaying the mean pain score over a period of 7 weeks, with a 3-week dose titration period, a 4-week fixed dose period, and three different groups: a placebo group, a group taking 1800mg/day of gabapentin, and a group taking 2400mg/day of gabapentin. The chart shows that the gabapentin groups had a significantly lower mean pain score compared to the placebo group (p<0.001).*
Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Gabapentin Fig3)
This text appears to be displaying some statistical data related to two studies. The "Percentage of Responders at Endpoint" is shown. Two p-values are given, one less than 0.01 and another less than 0.0001. The names of the studies (Study 1 and Study 2) are also mentioned.*
Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig4)
Gabapentin 800mg (Gabapentin Fig5)
This is a description of a medication identified as Gabapentin 800mg. The medication comes in a bottle with 90 biconvex, elliptical, white, film-coated tablets, and each tablet contains Gabapentin USP 800mg. The tablets have a break line on both sides with ‘D’ and ‘25’ on either side of the break line on one side and plain on the other side. The NDC for the medication is 63187-148-90, and the product ID is PG014890. It is RX-only medication manufactured by Aurobindo Pharma Limited Unit-VII in India. The medication should be stored at 20°-25°C (68°-77°F), and it is important to keep it out of the reach of children. The lot number is 00000, and the expiration date is 00/00/00. The medication was packaged by Proficient Rx LP in Thousand Oaks, CA 91320.*
Chemical Structure (Gabapentin Str)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
